Yellow Flower
Yellow Flower
Yellow Flower

Monitor

Estimates

Streamlined and Structured Investor Relations

Streamlined and Structured Investor Relations

How Monitor & Estimates Support CellaVision

How Monitor & Estimates Support CellaVision
As a Mid-Cap company with limited resources for Investor Relations, having the right tools is essential. By using Monitor, Estimates, and other Modular Finance products, CellaVision benefits from a cost-efficient solution that offers intuitive platforms and top-tier data — allowing more time to focus on value-adding activities instead of administrative tasks.

In what ways has Monitor made a difference for Cellavision?

Since we started using Monitor in 2021, the user-friendliness, overview of ownerships, and investor contacts have made a real difference in our daily work.





The platform gives us a complete understanding of current investor trends, which allows us to make smarter decisions on how we prioritise our time and efforts. Combining that with the investor targeting features really allows us to identify and reach out to investors with better precision.





Before switching to Monitor, preparing for investor meetings was a more time-consuming process. Now, we have everything we need in one place, making preparation, follow-ups and measurability much more efficient.

You are also using Estimates, what would you say is the biggest advantage of that service?

For us, it has been a really smooth way to feel in full control of our analyst consensus. The entire process of collecting, processing, and distributing the consensus can be really time-consuming and by using Estimates we can spend more time where it matters.

Finally, I really like that I can have the data integrated in Monitor, giving us a clear overview and making the data more actionable.

You also use MFN, Strictlog, and Datablocks. What advantage do you see in consolidating vendors?

Each product has its own reasons, but switching to Modular Finance for multiple IR needs was a logical decision. It’s simply more cost-effective, instead of juggling multiple vendors and contracts, we get better pricing by combining to Modular Finance’s products. 



Also, having one point of contact for multiple IR workflows - and with the level of customer service that Modular Finance has shown - is something that we have valued greatly.

In what ways has Monitor made a difference for Cellavision?

Since we started using Monitor in 2021, the user-friendliness, overview of ownerships, and investor contacts have made a real difference in our daily work.





The platform gives us a complete understanding of current investor trends, which allows us to make smarter decisions on how we prioritise our time and efforts. Combining that with the investor targeting features really allows us to identify and reach out to investors with better precision.





Before switching to Monitor, preparing for investor meetings was a more time-consuming process. Now, we have everything we need in one place, making preparation, follow-ups and measurability much more efficient.

You are also using Estimates, what would you say is the biggest advantage of that service?

For us, it has been a really smooth way to feel in full control of our analyst consensus. The entire process of collecting, processing, and distributing the consensus can be really time-consuming and by using Estimates we can spend more time where it matters.

Finally, I really like that I can have the data integrated in Monitor, giving us a clear overview and making the data more actionable.

You also use MFN, Strictlog, and Datablocks. What advantage do you see in consolidating vendors?

Each product has its own reasons, but switching to Modular Finance for multiple IR needs was a logical decision. It’s simply more cost-effective, instead of juggling multiple vendors and contracts, we get better pricing by combining to Modular Finance’s products. 



Also, having one point of contact for multiple IR workflows - and with the level of customer service that Modular Finance has shown - is something that we have valued greatly.

8 apr. 2025

About

Cellavision

Industry

Medical technology

Medical technology

MCAP (at publish)

€350 million

€350 million

Index

Mid Cap Stockholm

Mid Cap Stockholm

Interview with

Magnus Blixt
Magnus Blixt
CFO
Cellavision

Modular Finance products

Other Customer Cases

Recommendations

Product, articles and cases based on this customer case

Product, articles and cases based on this customer case

Book a demo

We are happy to answer any questions, or schedule a short meeting to demonstrate our products.


We usually respond within 10 minutes.

modular finance demo

Book a demo

We are happy to answer any questions, or schedule a short meeting to demonstrate our products. We usually respond within 10 minutes.

about modular finance demo
about modular finance demo

Want to know more?

We are happy to answer any questions, or schedule a short meeting.


Fill out the form, and we’ll get back to you.

United Kingdom

85 Gresham Street

EC2V 7NQ London





Sweden

Döbelnsgatan 24
SE-113 52 Stockholm


Tel: +46 (0) 8 400 650 06
info@modularfinance.com

Sign up to our newsletter to receive trend reports and e-books

By submitting this form I agree that Modular Finance may collect, process and retain my data pursuant to its Privacy Policy.


United Kingdom

85 Gresham Street

EC2V 7NQ London





Sweden

Döbelnsgatan 24
SE-113 52 Stockholm


Tel: +46 (0) 8 400 650 06
info@modularfinance.com

Sign up to our newsletter to receive trend reports and e-books

By submitting this form I agree that Modular Finance may collect, process and retain my data pursuant to its Privacy Policy.


Sweden

Döbelnsgatan 24
SE-113 52 Stockholm


Tel: +46 (0) 8 400 650 06
info@modularfinance.com

Sign up to our newsletter to receive trend reports and e-books

By submitting this form I agree that Modular Finance may collect, process and retain my data pursuant to its Privacy Policy.